Webinar: From Mutation to Treatment: Understanding the Impact of IDH Inhibitors
Webinar: From Mutation to Treatment: Understanding the Impact of IDH Inhibitors
Join this webinar to learn about the role of IDH inhibitors in brain tumor care and explore the latest advancements in IDH-targeted therapies, including the newly FDA-approved treatment, vorasidenib. In this Webinar, you will: Understand what IDH inhibitors are and how they are diagnosed Learn about how IDH inhibitors influence treatment decisions Recognize the role […]